Cefotiam dihydrochloride is primarily used as an antibiotic in the treatment of various bacterial infections. It is effective against a wide range of Gram-positive and Gram-negative bacteria, making it suitable for respiratory tract infections, urinary tract infections, and skin infections. In clinical settings, it is often administered intravenously or intramuscularly to ensure rapid and effective delivery into the bloodstream. Its broad-spectrum activity makes it a valuable option in hospitals for treating infections caused by susceptible organisms. Additionally, it is utilized in surgical prophylaxis to prevent postoperative infections, particularly in procedures involving the gastrointestinal or respiratory systems. Its ability to penetrate tissues effectively enhances its utility in such preventive measures. Cefotiam dihydrochloride is also employed in cases where patients have compromised immune systems, providing a reliable defense against opportunistic bacterial infections. Its stability and efficacy contribute to its widespread use in both acute and chronic infection management.